SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Tenet Healthcare Corporation New
THC
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Last trade$283.41
Day change-$8.13 (-2.79%)
Day range$281.74 – $292.96
Volume217,464
Market cap$23.20B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$23.2B
Price / earnings
8×
Price / book
4.26×
Price / sales
1.04×
EV / sales
1.52×
EV / EBITDA
6.84×
Profitability
Earnings per share
$36.43
Return on assets
9.18%
Return on equity
53.25%
Dividend yield
0%
Liquidity and leverage
Debt / equity
2.47×
Current ratio
1.58×
Quick ratio
1.52×
Cash ratio
0.5×
Cash flow
Price / cash flow
5.48×
Price / free cash flow
6.97×
Free cash flow
$3.33B
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for THC, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$5.63B
$5.63B
$5.78B
$5.35B
$5.29B
$5.27B
$5.22B
$4.89B
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$5.63B
$5.63B
$5.78B
$5.35B
$5.29B
$5.27B
$5.22B
$4.89B
Selling, general and administrative
$2.17B
$2.23B
$2.17B
$2.22B
$2.2B
$2.16B
$2.12B
$2.09B
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$4.6B
$4.23B
$4.54B
$4.76B
$4.48B
$4.47B
$4.36B
$7.25B
Operating income
$1.03B
$1.4B
$1.24B
$590M
$805M
$800M
$865M
-$2.36B
Interest expense
-$203M
-$204M
-$205M
-$205M
-$206M
-$206M
-$204M
-$203M
Income before taxes
$1.58B
$1.34B
$1.13B
$681M
$712M
$642M
$765M
$655M
Income taxes
$360M
$295M
$226M
$37M
$133M
$120M
$143M
$83M
Net income
$1.22B
$1.05B
$906M
$644M
$579M
$522M
$622M
$572M
Net income attributable to common shareholders
$1B
$826M
$702M
$371M
$342M
$288M
$406M
$318M
EBITDA
$1.29B
$1.24B
$1.52B
$915M
$1.04B
$1.06B
$1.11B
-$2.12B
Basic earnings per share
$12.48
$9.89
$8.09
$4.25
$3.89
$3.16
$4.31
$3.34
Diluted earnings per share
$12.41
$9.84
$8.01
$4.22
$3.86
$3.14
$4.27
$3.32
Recent news
Company coverage with links to the original publishers.
Tenet Healthcare (THC) is featured as a stock to watch with a #3 (Hold) Zacks Rank and an A-rated VGM Score. The company benefits from attractive valuation metrics including a forward P/E ratio of 13.08, and five analysts have revised earnings estimates upward in the last 60 days, with the consensus estimate increasing to $21.87 per share.
Tenet Healthcare (THC) is highlighted as a potential investment opportunity with a #3 (Hold) Zacks Rank and an A VGM Score. The company shows strong growth prospects with forecasted year-over-year earnings growth of 30.3% for the current fiscal year, supported by five analyst upward earnings revisions in the last 60 days. With a B Growth Style Score and average earnings surprise of +31%, THC is recommended for growth-focused investors.
Following Democrats' strong performance in the 2026 midterm elections, AI and data center stocks face increased regulatory risks, particularly in key states like Texas where data center moratoriums are being considered. Investors are advised to diversify toward consumer-focused ETFs, which are supported by strong consumer spending, robust holiday sales forecasts, and potential healthcare policy improvements.
Tenet Healthcare (THC) has been trending on Zacks.com with shares up 3.2% over the past month. The company shows strong earnings growth expectations of +30.3% for the current fiscal year and has consistently beaten consensus estimates. However, it received a Zacks Rank #3 (Hold) rating, suggesting it may perform in line with the broader market in the near term. The stock is valued at a discount to peers with an A grade on the Value Style Score.
Tenet Healthcare (THC) exceeded Q3 earnings expectations with adjusted EPS of $6.64 (79.5% YoY growth) and revenues of $5.63B (6.5% growth). The company raised full-year adjusted EBITDA guidance to $5.05-$5.20B, supported by $147M in Conifer transition benefits. USPI ambulatory segment showed strong performance with 9.1% EBITDA growth, while hospital admissions rose 3.2%. Management acknowledged 2027 headwinds from nonrecurring benefits and reimbursement uncertainty.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.